Australia’s Therapeutic Goods Administration (TGA) has recently approved a new COVID booster. The shot was developed by ...

There's one big difference though - Pfizer is seeking a green light for second booster dose of Comirnaty for people aged 60 and over and those in high-risk groups, while Moderna is going for a ...

The top-line beat was led by its higher than anticipated sales of Covid-19 vaccine, while its recently approved respiratory ...

Hence, researchers recommended that people who received it get a second booster dose with an mRNA vaccine such as Moderna and Pfizer. According to the published results, there were 129 coronavirus ...

Who's eligible for a booster? If you got Pfizer or Moderna, you're eligible for a booster if you're 65 years of age or older. If you're age 18 or older and you live in a long-term care setting.

The Cambridge-based company’s latest COVID shot was approved three weeks earlier than last year, according to a statement ...

With the help of TBWA\Chiat\Day New York, pharma giant Moderna is demystifying mRNA science for the average consumer. This ...

Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...

Moderna (MRNA) stock gains as company posts better than expected Q3 results driven by its updated COVID-19 vaccine. Read more ...

Moderna Inc. delivered better-than-expected profit and sales in the third quarter after an early start to sales of this season’s Covid boosters. The company’s latest Covid shot was approved ...